Related Experiment Video
Updated: Jan 1, 2026
06:16
Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments
Published on: May 9, 2019
8.0K
Clinical and Basic Research on Renshen Yangrong Decoction
Wei Sheng1,2, Yun Wang3, Jiang-Bo Li4
1School of Mental Health, Bengbu Medical College, Anhui, China.
Frontiers in Nutrition
|December 19, 2019
Summary
Renshen Yangrong Decoction shows promise for treating fatigue and deficiency diseases by enhancing hematopoietic and immune functions. Recent research highlights its potential in managing various chronic conditions.
Area of Science:
- Traditional Chinese Medicine
- Pharmacology
- Immunology
- Hematology
Background:
- Renshen Yangrong Decoction (RYD) is a traditional Chinese herbal formula.
- It is historically used for asthenic diseases, characterized by exhaustion and qi/blood deficiency.
- RYD is recognized for its potential to modulate hematopoietic and immune functions.
Purpose of the Study:
- To provide an overview of fundamental research on RYD.
- To focus on RYD's hematopoietic and immune-modulating effects.
- To review the recent clinical research status for RYD in treating specific diseases.
Main Methods:
- Literature review of fundamental research.
- Analysis of studies on hematopoietic function.
- Examination of research on immune functions.
- Survey of recent clinical trial data.
Main Results:
- RYD demonstrates significant hematopoietic and immune-enhancing properties.
- Clinical studies indicate RYD's efficacy in managing fatigue and sleep disorders.
- RYD shows potential benefits for coronary heart disease, diabetic complications, tumors, and brain injury.
Conclusions:
- RYD possesses notable hematopoietic and immune-regulatory capabilities.
- Evidence supports RYD's therapeutic value in fatigue, sleep disorders, and other chronic conditions.
- Further clinical investigation is warranted to fully establish RYD's efficacy and safety profile.
